Bone turnover and hormonal perturbations in patients with fibromyalgia

Clinical and Experimental Rheumatology

Volumn 24, Issue 4, 2006, Pages 428-431

  El Maghraoui, Abdellah ^a   Tellal, Saida ^a   Achemlal, Lahsen ^a   Nouijai, Abderrazak ^a   Ghazi, Merieme ^a   Mounach, Aziza ^a   Bezza, Ahmed ^a   Derouiche, El Mostapha ^a  

^a MILITARY HOSPITAL MOHAMMED V   (Morocco)

Author keywords

Bone turnover; Fibromyalgia; Hypothalamic pituitary axis; Sex hormones

Indexed keywords

ALBUMIN; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; ESTROGEN; ESTRONE; FOLLITROPIN; LUTEINIZING HORMONE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; PROLACTIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BONE TURNOVER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; FATIGUE; FEMALE; FIBROMYALGIA; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; OSSIFICATION; OSTEOLYSIS; PAIN ASSESSMENT; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; BONE REMODELING; BONE RESORPTION; COLLAGEN TYPE I; FEMALE; FIBROMYALGIA; GONADAL HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDES; PITUITARY-ADRENAL SYSTEM;

EID: 33748535735     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. NøORREGAARD J, BÜLOW PM, LYKKEGAARD JJ, DANNESKIOLD-SAMSøOE B: Muscle strength, working capacity and effort in patients with fibromyalgia. Scand J Rehab Med 1997; 29: 97-102.
2. RIIS BJ: Biochemical markers of bone turnover II: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993; 95: 17-24.
3. UEBELHART D, GINEYTS E, CHAPUY MC, DELMAS PD: Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 1990; 8: 87-96.
4. EL MAGHRAOUI A, BORDERIE D, EDOUARD R, ROUX C, DOUGADOS M: Osteoporosis, body composition and bone turnover in ankylosing spondylitis. J Rheumatol 1999; 26: 2205-9
5. EL MAGHRAOUI A, TELLAL S, CHAOUIR S et al.: Bone turnover markers, anterior pituitary and gonadal hormones, and bone mass evaluation using quantitative computed tomography in ankylosing spondylitis. Clinical Rheumatology 2005; 24: 346-51
6. ACHEMLAL L, TELLAL S, RKIOUAK F et al.: Bone metabolism in male patients with type 2 diabetes. Clinical Rheumatology 2005; 24: 493-6.
7. SWEZEY RL, ADAMS J: Fibromyalgia: a risk factor for osteoporosis. J Rheumatol 1999; 26: 2642-4.
8. ZERAN B, BLIDDAL H, MøOLLER P, BORGWARDT A, DANNESKIOLD-SAMSÖE B: Bone mass in the calcaneus in patients with fibromyalgia. J Musculoskel Pain 2001; 9: 17-23.
9. AL-ALLAF AW, MOLE PA, PATERSON CR, PULLAR T: Bone health in patients with fibromyalgia. Rheumatology 2003; 42: 1202-6.
10. JENSEN B, WITTRUP IH, BLIDDAL H, DANNESKIOLD-SAMSøOE B, FABER J: Bone mineral density in fibromyalgia patients - correlation to disease activity. Scand J Rheumatol 2003; 32:146-50
11. AKKUS S, DELIBAS N, TAMER MN: Do sex hormones play a role in fibromyalgia? Rheumatology (Oxford) 2000; 39: 1161-3.
12. KORSZUN A, YOUNG AE, ENGLEBERG NC et al.: Follicular phase hypothalamic-pituitary-gonadal axis function in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 2000; 27: 1526-30.
13. CROFFORD LJ, PILLEMER SR, KALOGERAS KT et al.: Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994; 37: 1583-92.
14. MCAIN GA, TILBE KS: Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol Suppl 1989; 19:154-7.
15. GRIEP EN, BOERSMA JW, DE KLOET ER: Altered reactivity of the hypothalamic pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993; 20: 469-74.
16. GRIEP EN, BOERSMA JW, LENTJES EG, PRINS AP, VAN DER KORST JK, DE KLOET ER: Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 1998; 25: 1374-81.
17. WOLFE F, SMYTHE HA, YUNUS MB et al.: The American College of Rheumatology 1990. Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33:160-72.
18. APPELBOOM T, SCHOUTENS A: High bone turnover in fibromyalgia. Calcif Tissue Int 1990; 46: 314-7.
19. JACOBSEN S, GAM A, EGSMOSE C, OLSEN M, DANNESKIOLD-SAMSøOE B, JENSEN GF: Bone mass and turnover in fibromyalgia. J Rheumatol 1993; 20: 856-9.
20. SPROTT H, MULLER A, HEINE H: Collagen crosslinks in fibromyalgia. Arthritis Rheum 1997; 40: 1450-4.
21. NEECK G: Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients. Scand J Rheumatol 2000; 29: 8-12.
22. CROFFORD LJ: The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and CFS. Z Rheumatol 1998; 57: 67-71.
23. TSIGOS C, CHROUSOS GP: Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002; 53: 865-71.
24. RIEDEL W, LAYKA H, NEECK G: Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Z Rheumatol 1998; 57 (Suppl. 2): 81-7.
25. GUR A, CEVIK R, SARAC AJ, COLFAN L ANDEM S: Hypothalamic-pituitary-gonadal axis and cortisol disturbance in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep in the occurrence of hypocortisolism Ann Rheum Dis 2004; 63; 1504-6.